JESSICA ROELKEY: Open Payments
NPI 1619390424 · BOONSBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 39 payments from 8 companies in 2025. Trend: 2023 $470 · 2024 $609 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $271 |
| Novo Nordisk Inc | 10 | $184 |
| ABBVIE INC. | 10 | $145 |
| PFIZER INC. | 2 | $45 |
| Seqirus USA Inc | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Lilly USA, LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
Products named: AIRSUPRA, VRAYLAR, Ozempic, FARXIGA, BREZTRI, UBRELVY, Wegovy, Rybelsus.
Industry payments across MD — which companies pay providers there.
